Biocon receives USFDA approval for HER2-positive breast canc
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
The US Food and Drug Administration approved the Biocon and US drug maker Mylan's proposed biosimilar breast cancer drug Trastuzumab which is a high-quality, affordable option for treating HER2-positive breast cancers...


http://bit.ly/2tSQALk
Like
Comment
Share